Patients undergoing dialysis, especially those with diabetes as the primary renal disease, face a high risk for lower limb amputation and mortality after amputation, a cohort study finds.

Wrestling legend Konnan reportedly risks another leg amputation after severe medical issues forced doctors to remove one leg.

Risk of recurrent major adverse limb events was lower in diabetes patients taking GLP-1 agents compared with DPP-4 inhibitors. Reduction of limb events was most significant for major amputations, ...